Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4557383
Max Phase: Preclinical
Molecular Formula: C18H27N
Molecular Weight: 257.42
Molecule Type: Unknown
Associated Items:
ID: ALA4557383
Max Phase: Preclinical
Molecular Formula: C18H27N
Molecular Weight: 257.42
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC1=C(/C=C/C=C/C=C/C=C/CN)C(C)(C)CCC1
Standard InChI: InChI=1S/C18H27N/c1-16-12-11-14-18(2,3)17(16)13-9-7-5-4-6-8-10-15-19/h4-10,13H,11-12,14-15,19H2,1-3H3/b6-4+,7-5+,10-8+,13-9+
Standard InChI Key: MZLMLNVUJMQXJF-IGEUGCNCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 257.42 | Molecular Weight (Monoisotopic): 257.2143 | AlogP: 4.70 | #Rotatable Bonds: 5 |
Polar Surface Area: 26.02 | Molecular Species: BASE | HBA: 1 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.64 | CX LogP: 4.10 | CX LogD: 1.92 |
Aromatic Rings: 0 | Heavy Atoms: 19 | QED Weighted: 0.71 | Np Likeness Score: 1.59 |
1. (2017) Compounds and methods of treating ocular disorders, |
Source(1):